Cite
HARVARD Citation
Kamei, J. et al. (2022). Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney. IJU case reports. 5 (3), pp. 199-202. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kamei, J. et al. (2022). Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney. IJU case reports. 5 (3), pp. 199-202. [Online].